KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Expenditures (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Capital Expenditures for 11 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 40.65% year-over-year to $4.5 million, compared with a TTM value of $31.4 million through Dec 2025, down 14.21%, and an annual FY2025 reading of $31.4 million, down 14.21% over the prior year.
  • Capital Expenditures was $4.5 million for Q4 2025 at Medpace Holdings, down from $10.7 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $12.9 million in Q2 2024 and bottomed at $4.5 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $8.5 million, with a median of $8.9 million recorded in 2021.
  • The sharpest move saw Capital Expenditures surged 86.42% in 2022, then plummeted 52.51% in 2025.
  • Year by year, Capital Expenditures stood at $9.1 million in 2021, then rose by 1.39% to $9.2 million in 2022, then increased by 8.04% to $10.0 million in 2023, then decreased by 23.46% to $7.6 million in 2024, then crashed by 40.65% to $4.5 million in 2025.
  • Business Quant data shows Capital Expenditures for MEDP at $4.5 million in Q4 2025, $10.7 million in Q3 2025, and $6.1 million in Q2 2025.